Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Organ Market Value Growth And Long-Term Outlook
The artificial organ market has experienced rapid expansion recently. This market is projected to expand from $25.73 billion in 2025 to $28.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.2%. Historically, this growth has been driven by factors such as a rise in organ failure incidents, a scarcity of available donor organs, significant progress in biomedical engineering, the increasing adoption of dialysis and cardiac support treatments, and longer transplant waiting lists.
The artificial organ market is projected to experience robust expansion over the coming years. The market is set to expand to $41.12 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.7%. This anticipated growth is due to several factors, including heightened investments in bioengineered organs, increased uptake of personalized implant solutions, expanded funding for artificial organ research, advancements in regenerative medicine technology, and greater acceptance of long-term implantable devices. Key trends anticipated during this period encompass a rise in the adoption of implantable artificial organs, an increasing utilization of advanced biomaterials, the growing incorporation of smart and sensor-enabled organs, an expansion of minimally invasive implantation techniques, and a stronger emphasis on long-term biocompatibility.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Organ Market Development Factors: What’s Supporting Demand?
The growing need for organ transplants is anticipated to fuel the expansion of the artificial organ market in the future. Organ transplantation involves a surgical intervention where an organ or tissue from a donor is placed into a recipient to substitute an impaired or non-functioning organ. Artificial organ advancements aid organ transplants by offering provisional or permanent replacement organs, lessening reliance on donor availability, and enhancing patient survival rates. To illustrate this, a report from NHS Blood and Transplant, a UK government body, indicated in July 2025 that as of March 2025, an unprecedented 8,096 patients (comprising 276 children) were on the active transplant waiting list, with an additional 3,883 individuals temporarily paused. Consequently, the heightened demand for organ transplants is boosting the growth of the artificial organ market.
Artificial Organ Market Segment Trends And Revenue Contributors
The artificial organ market covered in this report is segmented –
1) By Organ Type: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas
2) By Material: Silicone, Plastic, Steel, Biomaterials
3) By Fixation: Implantable, External
4) By End Users: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Artificial Heart: Total Artificial Heart, Ventricular Assist Devices (VADs)
2) By Artificial Kidney: Hemodialysis Systems, Peritoneal Dialysis Devices
3) By Artificial Liver: Bioartificial Liver Devices, Liver Support Systems
4) By Artificial Pancreas: Closed-Loop Insulin Delivery Systems, Bionic Pancreas Systems
Artificial Organ Market Transformation Trends: What Innovations Are Driving Change?
Leading companies operating in the artificial organ market are concentrating on innovative products like AI-powered pathology solutions to increase their market revenues. AI-powered pathology solutions are transforming the field of pathology by offering pathologists powerful tools to enhance diagnostic accuracy, efficiency, and patient care. For example, in September 2023, Aiosyn, a Netherlands-based medical software company specializing in AI-powered pathology solutions, launched an AI kidney suite. This new suite aims to objectively quantify kidney lesion ratings to improve repeatability and accelerate medication discovery through the application of AI-powered computational pathology techniques. The new platform allows research organizations and biopharma to analyze kidney structures and quantify lesions that impact kidney health by utilizing cutting-edge deep-learning technology.
Artificial Organ Market Industry Leaders And Competitive Landscape
Major companies operating in the artificial organ market are Medtronic plc, Abbott Laboratories Inc., SynCardia Systems LLC, Berlin Heart GmbH, ABIOMED Inc., Carmat SA, Jarvik Heart Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Organovo Holdings Inc., Satellite Bio, HeartWare plc, Boston Scientific Services Private Limited, Edwards Lifesciences India Pvt. Ltd., LIVANOVA plc, NeuroPace Inc., Cochlear Limited, Cyberonics Inc., Demant A/S, LifeNet Health Inc., Vivani Medical Inc., Tissium SAS
View The Full Artificial Organ Market Report:
Artificial Organ Market Regional Analysis And Leading Geography
North America was the largest region in the artificial organ market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organ market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
